bin guo

Dr. bin guo

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2023 in Drug Delivery
Verified
Journal Article
Open access
LZLianghui Zhao
Lianghui Zhao
JSJike Song
Jike Song
YDYongle Du
Yongle Du
CRCong Ren
Cong Ren
BGbin guo
bin guo
HBHongsheng Bi
Hongsheng Bi
Traditional ophthalmic drugs, such as eye drops, gels and ointments, are accompanied by many problems, including low bioavailability and potential drug side effects. Innovative ophthalmic drug delivery systems have been proposed to overcome the limitations associated with traditional formulations. Recently, contact lens-based drug delivery systems have gained popularity owing to their advantages of sustained drug delivery, prolonged drug retention, improved bioavailability, and few drug side effects. Various methods have been successfully applied to drug-loaded contact lenses and prolonged the drug release time, such as chemical crosslinking, material embedding, molecular imprinting, colloidal nanoparticles, vitamin E modification, drug polymer film/coating, ion ligand polymerization systems, and supercritical fluid technology. Contact lens-based drug delivery systems play an important role in the treatment of multifarious ophthalmic diseases. This review discusses the latest developments in drug-loaded contact lenses for the treatment of ophthalmic diseases, including preparation methods, application in ophthalmic diseases and future prospects.

6 May 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HSHao Sun
Hao Sun
GWGaolei Wang
Gaolei Wang
CRCong Ren
Cong Ren
XZXi Zhang
Xi Zhang
PZPing Zhao
Ping Zhao
BGbin guo
bin guo
Erianin, extracted from Dendrobium chrysotoxum Lindl, has shown significant antitumour activity in various cancers, including bladder, cervical, and nasopharyngeal carcinoma. This study explores Erianin’s impact on melanoma, a prevalent intraocular malignancy in adults, emphasizing cell growth inhibition and its mechanism. Vascular endothelial growth factor-α (VEGF-α), a validated therapeutic target in uveal melanoma angiogenesis, was considered. Despite its origin from Dendrobium plants in the Orchidaceae family, Erianin’s anti-melanoma effects and its potential to inhibit the PI3K/AKT/mTOR signalling pathway to decrease VEGF-α secretion in melanoma cells remain unexplored. Thus, Erianin’s effects on A375 cells and its underlying molecular mechanisms were investigated. Erianin induced apoptosis in A375 cells, as demonstrated by flow cytometry and western blot assays. Additionally, Erianin inhibited A375 cell migration, proliferation, and invasion in vitro, evidenced by cell scratch, EdU stain, and transwell cell invasion assays. Mechanistically, Erianin downregulated VEGF-α and VEGF Receptor 2 expression while inhibiting PI3K/AKT pathway activation, indicated by western blot and immunofluorescence analyses. Furthermore, both western blot and immunofluorescence analyses confirmed Erianin’s regulation of VEGF-α and VEGFR2 expression. This study suggests that Erianin is a novel compound capable of inducing cell apoptosis while suppressing the activation of the VEGF/PI3K/AKT signalling pathway in A375 cells, thereby inhibiting cell proliferation.

28 February 2023 in Ophthalmic Research
Verified
Journal Article
Open access
PDF file
RLRunkuan Li
Runkuan Li
XGXiaoxiao Guo
Xiaoxiao Guo
XZXiuyan Zhang
Xiuyan Zhang
XLXiuzhen Lu
Xiuzhen Lu
QWQiuxin Wu
Qiuxin Wu
HBHongsheng Bi
Hongsheng Bi
Introduction: The aim of this study was to quantitatively assess fundus tessellated density (FTD) and associated factors by artificial intelligence (AI) in young adults. Methods: A total of 1,084 undergraduates (age, 17–23 years old) were enrolled in November 2021. The students were divided into three groups according to axial length (AL): group 1 (AL <24.0 mm, n = 155), group 2 (24 mm ≤ AL <26 mm, n = 578), and group 3 (AL ≥26 mm, n = 269). FTD was calculated by extracting the fundus tessellations as the regions of interest (circle 1, diameter of 3.0 mm; circle 2, diameter of 6.0 mm) and then calculating the average exposed choroid area per unit area of fundus. Results: Among 1,084 students, 1,002 (92.5%) students' FTDs were extracted. The mean FTD was 0.06 ± 0.06 (range, 0–0.40). In multivariate analysis, FTD was significantly associated with male sex, longer AL, thinner subfoveal choroid thickness (SFCT), increased choriocapillaris vessel density (VD), and decreased deeper choroidal VD (all p < 0.05). In circle 1 (diameter of 3.0 mm) and circle 2 (diameter of 6.0 mm), analysis of variance showed that the FTD of the nasal region (p < 0.05) was significantly larger than that of the superior, inferior, and temporal regions. Conclusion: AI-based imaging processing could improve the accuracy of fundus tessellation diagnosis. FTD was significantly associated with a longer AL, thinner SFCT, increased choriocapillaris VD, and decreased deeper choroidal VD.

28 May 2025 in Materials Today Bio
Verified
Journal Article
Open access
LZLianghui Zhao
Lianghui Zhao
XDXiaoyun Dong
Xiaoyun Dong
BGbin guo
bin guo
JSJike Song
Jike Song
HBHongsheng Bi
Hongsheng Bi
Myopia, a predominant cause of visual impairment, is often associated with scleral extracellular matrix (ECM) remodeling and axial elongation. Currently, effective therapeutic strategies for addressing scleral ECM remodeling remain limited, necessitating the development of new treatments. Quercetin, a natural flavonoid, has been shown to alleviate ECM remodeling. However, its hydrophobic nature limits clinical application. To address this, we developed a quercetin-loaded exosome delivery system (Exo-Que) to enhance quercetin bioavailability and investigated its effects and mechanisms in myopia prevention. This system exhibited excellent aqueous solubility, enhanced corneal permeability, and prolonged precorneal retention, enabling low-dose administration with significant efficacy. In the initial phase of treatment, Exo-Que showed a pronounced myopia prevention effect, with reductions of 58.41 % in refractive error progression and 38.46 % in axial length growth after two weeks of treatment. As the treatment duration extended to four weeks, its therapeutic efficacy remained robust, achieving reductions of 59.97 % and 35.85 %, respectively. The therapeutic efficacy of Exo-Que was comparable to that of the 0.1 % atropine group (at two weeks, reducing 59.07 % and 35.9 %, respectively; at four weeks, 59.84 % and 37.74 %, respectively). Mechanistically, Exo-Que inhibited the activation of the IRE1-XBP1, PERK-eIF2, and ATF6 pathways, alleviating endoplasmic reticulum stress. Furthermore, it suppressed ferroptosis by modulating GRP78-ACSL4 and GRP78-GPX4 protein interactions, thus mitigating ECM remodeling and slowing myopia progression. Besides, Exo-Que showed excellent biosafety in both in vitro and in vivo studies. Collectively, these results highlight the promising therapeutic potential of Exo-Que for myopia prevention.

17 November 2023 in Medicine
Verified
Journal Article
Open access
聪R聪 Ren
聪 Ren
ZLZhongen Mm Li
Zhongen Mm Li
FMFan Meng
Fan Meng
YDYongle Bmed Du
Yongle Bmed Du
HSHao Mm Sun
Hao Mm Sun
BGbin guo
bin guo
Rationale: Endogenous endophthalmitis is a vision-threatening intraocular infection caused by hematogenous spread of infectious organisms from distant sites. Patient concerns: A 71-year-old man with a history of fever and dysuria 5 days prior to presentation presented with sudden loss of vision in his left eye. The patient had no history of ocular surgery or trauma, and ocular examination revealed a large amount of exudative plaque covering the pupil. Therefore, fundus examination was not feasible. B-scan ultrasonography revealed a dome-shaped subretinal mass with an exudative retinal detachment. Diagnosis: Endogenous endophthalmitis was diagnosed on the basis of these findings. Interventions: The patient underwent pars plana vitrectomy and the early postoperative course was favorable. Outcomes: Vitreous cultures grew gram-negative bacilli, identified as Klebsiella pneumonia. Urinalysis revealed white blood cells (++) and urinary tract infection was the only identifiable risk factor for endogenous endophthalmitis. Lessons: Urinary tract infection is an independent risk factor for endogenous endophthalmitis.

22 February 2025 in European Journal of Pharmacology
Verified
Journal Article
Open access
DZDiya Zhang
Diya Zhang
CRCong Ren
Cong Ren
XWXuan Wang
Xuan Wang
WCWenbo Cao
Wenbo Cao
MYMingkun Yu
Mingkun Yu
BGbin guo
bin guo
This study is a systematical review regarding the glaucoma treatment with drug-loaded contact lenses. The effectiveness and safety about that were summarized, which providing effective suggestions and guidance for clinical research. The studies published up to May 1, 2024 on the treatment of glaucoma with sustained-release contact lenses were searched from CNKI, Wanfang Data, VIP, PubMed, Embase, Cochrane Library, and Medline. CAMARADES was used to evaluate literature quality. The safety, endpoints of intraocular pressure reduction (IOPR) and duration of intraocular pressure (IOP) decline during glaucoma treatment were analyzed by means of qualitative and quantitative methods. The protocol registration number is CRD42024487157. 47 studies were included. In clinical trials, glaucoma patients showed a 50% reduction in IOP and no corneal tissue destruction after wearing contact lenses. In animal experiments, the endpoint IOPR [MD = 0.58, 95%CI (0.37, 0.80), P < 0.00001] of the medicated contact lenses group was significantly better than that of the eye drops group. Subgroup analysis showed that contact lenses loaded with timolol (TML), with TML + dorzolamide, and with TML + latanoprost, which compared to eye drops, had a better effect on reducing IOP, while contact lenses loaded with puerarin, latanoprost, and TML + bimatoprost showed no statistical difference. Most studies demonstrated the duration of IOP reduction and drugs release in vitro for ≥3 days during contact lenses treatment. Most drug-loaded contact lenses exhibit excellent effectiveness and safety. The nanoparticle-loaded contact lenses containing TML for glaucoma treatment is recommended in future clinical research.